David P. Tusa - May 11, 2021 Form 4 Insider Report for SHARPS COMPLIANCE CORP (SMED)

Role
CEO and President, Director
Signature
Diana Diaz, on behalf of Reporting Person
Stock symbol
SMED
Transactions as of
May 11, 2021
Transactions value $
-$1,150,036
Form type
4
Date filed
5/13/2021, 05:04 PM
Next filing
May 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMED Common Stock Options Exercise $61.2K +16.1K +18.28% $3.80 104K May 11, 2021 Direct F1
transaction SMED Common Stock Sale -$270K -16.1K -15.45% $16.75 88.1K May 11, 2021 Direct F2
transaction SMED Common Stock Options Exercise $112K +29.6K +33.61% $3.80 118K May 12, 2021 Direct F1
transaction SMED Common Stock Sale -$489K -29.6K -25.15% $16.52 88.1K May 12, 2021 Direct F3
transaction SMED Common Stock Options Exercise $92.1K +24.2K +27.52% $3.80 112K May 13, 2021 Direct F1
transaction SMED Common Stock Sale -$391K -24.2K -21.58% $16.15 88.1K May 13, 2021 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMED Sharps Compliance 2010 Stock Plan Options Options Exercise -$61.2K -16.1K -4.14% $3.80 373K May 11, 2021 Common Stock 16.1K $3.80 Direct F1
transaction SMED Sharps Compliance 2010 Stock Plan Options Options Exercise -$112K -29.6K -7.94% $3.80 343K May 12, 2021 Common Stock 29.6K $3.80 Direct F1
transaction SMED Sharps Compliance 2010 Stock Plan Options Options Exercise -$92.1K -24.2K -7.06% $3.80 319K May 13, 2021 Common Stock 24.2K $3.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Cashless exercise and immediate sale through a broker of a stock award granted on February 13, 2019. All shares were issued under the Sharps Compliance Corp. 2010 Stock Plan and were scheduled to expire on February 13, 2026.
F2 This represents the weighted average sale of 16,100 shares. Shares were sold between a range of $16.70 and $16.92.
F3 This represents the weighted average sale of 29,603 shares. Shares were sold between a range of $16.42 and $16.99.
F4 This represents the weighted average sale of 24,238 shares. Shares were sold between a range of $16.15 and $16.40.